Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations
Year: 2018
Type: article
Abstract: While tumor genome sequencing has become widely available in clinical and research settings, the interpretation of tumor somatic variants remains an important bottleneck. Here we present the Cancer Genome Interpreter, a versatile platform that automates the interpretation of newly sequenced cancer genomes, annotating the potential of alterations detected in tumors to act as drivers and their possible effect on treatment response. The results are organized in different levels of evidence according to current knowledge, which we envision can support a broad range of oncology use cases. The resource is publicly available at http://www.cancergenomeinterpreter.org .
Source: Genome Medicine
Institutions: Universitat Pompeu Fabra, Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Municipal Institute for Medical Research, Hospital del Mar Research Institute, Charité – Universitätsmedizin Berlin, Universitat Autònoma de Barcelona, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Hospital Del Mar, Hospital Sant Joan de Déu Barcelona, Institut de Recerca Sant Joan de Déu, Institució Catalana de Recerca i Estudis Avançats
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $5,290
Funders: Eli Lilly and Company, Institute for Research in Biomedicine, Fundació la Marató de TV3, Centres de Recerca de Catalunya, Universitat Pompeu Fabra, European Commission, Generalitat de Catalunya, Ministerio de Economía y Competitividad, Institució Catalana de Recerca i Estudis Avançats, Universitat de Barcelona, Universitat Autònoma de Barcelona, European Research Council, European Regional Development Fund, Agencia Estatal de Investigación, H2020 European Research Council
Awards: G1275801773, G1852141302, G1888088267, G1953887145, G3371371070, G371890588, G434337789, G5705025502, G7877182146, G7897891268, Finding noncoding cancer drivers, Creating medically-driven integrative bioinformatics applications focused on oncology, CNS disorders and their comorbidities (MedBioinformatics), G8820132450
OpenAlex ID: W2949492942
